The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bi-Specific Antibodies Market Research Report 2025
Synopsis
A bispecific antibody (BsAb), or specific monoclonal antibody (BsMAb) is an artificial protein comprised of fragments from two different antibodies. By virtue of the inclusion of two different antigen binding regions, a bispecific antibody is capable of recognizing and binding to two different antigens, or two different epitope on an antigen.
The global Bi-Specific Antibodies market was valued at US$ 3266 million in 2023 and is anticipated to reach US$ 4147.6 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
Global Bi-Specific Antibodies Therapy key players include Roche, Amgen, Sanofi, Pfizer, Johnson & Johnson, etc. Global top five manufacturers hold a share over 95%.
North America is the largest market, with a share about 65%, followed by Europe and China, both have a share over 30 percent. In terms of product, IgG-Based Antibodies is the largest segment, with a share over 85%. And in terms of application, the largest application is Haemophilia, followed by Cancer, etc.
This report aims to provide a comprehensive presentation of the global market for Bi-Specific Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bi-Specific Antibodies.
Report Scope
The Bi-Specific Antibodies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bi-Specific Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bi-Specific Antibodies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche (Chugai)
Amgen
Segment by Type
Fragment-Based Antibodies
IgG-Based Antibodies
Segment by Application
Cancer
Haemophilia
Other Non-Cancer Diseases
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bi-Specific Antibodies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A bispecific antibody (BsAb), or specific monoclonal antibody (BsMAb) is an artificial protein comprised of fragments from two different antibodies. By virtue of the inclusion of two different antigen binding regions, a bispecific antibody is capable of recognizing and binding to two different antigens, or two different epitope on an antigen.
The global Bi-Specific Antibodies market was valued at US$ 3266 million in 2023 and is anticipated to reach US$ 4147.6 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
Global Bi-Specific Antibodies Therapy key players include Roche, Amgen, Sanofi, Pfizer, Johnson & Johnson, etc. Global top five manufacturers hold a share over 95%.
North America is the largest market, with a share about 65%, followed by Europe and China, both have a share over 30 percent. In terms of product, IgG-Based Antibodies is the largest segment, with a share over 85%. And in terms of application, the largest application is Haemophilia, followed by Cancer, etc.
This report aims to provide a comprehensive presentation of the global market for Bi-Specific Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bi-Specific Antibodies.
Report Scope
The Bi-Specific Antibodies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bi-Specific Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bi-Specific Antibodies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche (Chugai)
Amgen
Segment by Type
Fragment-Based Antibodies
IgG-Based Antibodies
Segment by Application
Cancer
Haemophilia
Other Non-Cancer Diseases
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bi-Specific Antibodies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bi-Specific Antibodies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Fragment-Based Antibodies
1.2.3 IgG-Based Antibodies
1.3 Market by Application
1.3.1 Global Bi-Specific Antibodies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Haemophilia
1.3.4 Other Non-Cancer Diseases
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bi-Specific Antibodies Market Perspective (2019-2030)
2.2 Bi-Specific Antibodies Growth Trends by Region
2.2.1 Global Bi-Specific Antibodies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Bi-Specific Antibodies Historic Market Size by Region (2019-2024)
2.2.3 Bi-Specific Antibodies Forecasted Market Size by Region (2025-2030)
2.3 Bi-Specific Antibodies Market Dynamics
2.3.1 Bi-Specific Antibodies Industry Trends
2.3.2 Bi-Specific Antibodies Market Drivers
2.3.3 Bi-Specific Antibodies Market Challenges
2.3.4 Bi-Specific Antibodies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bi-Specific Antibodies Players by Revenue
3.1.1 Global Top Bi-Specific Antibodies Players by Revenue (2019-2024)
3.1.2 Global Bi-Specific Antibodies Revenue Market Share by Players (2019-2024)
3.2 Global Bi-Specific Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bi-Specific Antibodies Revenue
3.4 Global Bi-Specific Antibodies Market Concentration Ratio
3.4.1 Global Bi-Specific Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bi-Specific Antibodies Revenue in 2023
3.5 Bi-Specific Antibodies Key Players Head office and Area Served
3.6 Key Players Bi-Specific Antibodies Product Solution and Service
3.7 Date of Enter into Bi-Specific Antibodies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bi-Specific Antibodies Breakdown Data by Type
4.1 Global Bi-Specific Antibodies Historic Market Size by Type (2019-2024)
4.2 Global Bi-Specific Antibodies Forecasted Market Size by Type (2025-2030)
5 Bi-Specific Antibodies Breakdown Data by Application
5.1 Global Bi-Specific Antibodies Historic Market Size by Application (2019-2024)
5.2 Global Bi-Specific Antibodies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Bi-Specific Antibodies Market Size (2019-2030)
6.2 North America Bi-Specific Antibodies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Bi-Specific Antibodies Market Size by Country (2019-2024)
6.4 North America Bi-Specific Antibodies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bi-Specific Antibodies Market Size (2019-2030)
7.2 Europe Bi-Specific Antibodies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Bi-Specific Antibodies Market Size by Country (2019-2024)
7.4 Europe Bi-Specific Antibodies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bi-Specific Antibodies Market Size (2019-2030)
8.2 Asia-Pacific Bi-Specific Antibodies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Bi-Specific Antibodies Market Size by Region (2019-2024)
8.4 Asia-Pacific Bi-Specific Antibodies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bi-Specific Antibodies Market Size (2019-2030)
9.2 Latin America Bi-Specific Antibodies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Bi-Specific Antibodies Market Size by Country (2019-2024)
9.4 Latin America Bi-Specific Antibodies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bi-Specific Antibodies Market Size (2019-2030)
10.2 Middle East & Africa Bi-Specific Antibodies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Bi-Specific Antibodies Market Size by Country (2019-2024)
10.4 Middle East & Africa Bi-Specific Antibodies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche (Chugai)
11.1.1 Roche (Chugai) Company Detail
11.1.2 Roche (Chugai) Business Overview
11.1.3 Roche (Chugai) Bi-Specific Antibodies Introduction
11.1.4 Roche (Chugai) Revenue in Bi-Specific Antibodies Business (2019-2024)
11.1.5 Roche (Chugai) Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Bi-Specific Antibodies Introduction
11.2.4 Amgen Revenue in Bi-Specific Antibodies Business (2019-2024)
11.2.5 Amgen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Bi-Specific Antibodies Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Fragment-Based Antibodies
Table 3. Key Players of IgG-Based Antibodies
Table 4. Global Bi-Specific Antibodies Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Bi-Specific Antibodies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Bi-Specific Antibodies Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Bi-Specific Antibodies Market Share by Region (2019-2024)
Table 8. Global Bi-Specific Antibodies Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Bi-Specific Antibodies Market Share by Region (2025-2030)
Table 10. Bi-Specific Antibodies Market Trends
Table 11. Bi-Specific Antibodies Market Drivers
Table 12. Bi-Specific Antibodies Market Challenges
Table 13. Bi-Specific Antibodies Market Restraints
Table 14. Global Bi-Specific Antibodies Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Bi-Specific Antibodies Market Share by Players (2019-2024)
Table 16. Global Top Bi-Specific Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bi-Specific Antibodies as of 2023)
Table 17. Ranking of Global Top Bi-Specific Antibodies Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Bi-Specific Antibodies Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Bi-Specific Antibodies Product Solution and Service
Table 21. Date of Enter into Bi-Specific Antibodies Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Bi-Specific Antibodies Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Bi-Specific Antibodies Revenue Market Share by Type (2019-2024)
Table 25. Global Bi-Specific Antibodies Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Bi-Specific Antibodies Revenue Market Share by Type (2025-2030)
Table 27. Global Bi-Specific Antibodies Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Bi-Specific Antibodies Revenue Market Share by Application (2019-2024)
Table 29. Global Bi-Specific Antibodies Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Bi-Specific Antibodies Revenue Market Share by Application (2025-2030)
Table 31. North America Bi-Specific Antibodies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Bi-Specific Antibodies Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Bi-Specific Antibodies Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Bi-Specific Antibodies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Bi-Specific Antibodies Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Bi-Specific Antibodies Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Bi-Specific Antibodies Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Bi-Specific Antibodies Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Bi-Specific Antibodies Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Bi-Specific Antibodies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Bi-Specific Antibodies Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Bi-Specific Antibodies Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Bi-Specific Antibodies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Bi-Specific Antibodies Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Bi-Specific Antibodies Market Size by Country (2025-2030) & (US$ Million)
Table 46. Roche (Chugai) Company Detail
Table 47. Roche (Chugai) Business Overview
Table 48. Roche (Chugai) Bi-Specific Antibodies Product
Table 49. Roche (Chugai) Revenue in Bi-Specific Antibodies Business (2019-2024) & (US$ Million)
Table 50. Roche (Chugai) Recent Development
Table 51. Amgen Company Detail
Table 52. Amgen Business Overview
Table 53. Amgen Bi-Specific Antibodies Product
Table 54. Amgen Revenue in Bi-Specific Antibodies Business (2019-2024) & (US$ Million)
Table 55. Amgen Recent Development
Table 56. Research Programs/Design for This Report
Table 57. Key Data Information from Secondary Sources
Table 58. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bi-Specific Antibodies Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Bi-Specific Antibodies Market Share by Type: 2023 VS 2030
Figure 3. Fragment-Based Antibodies Features
Figure 4. IgG-Based Antibodies Features
Figure 5. Global Bi-Specific Antibodies Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Bi-Specific Antibodies Market Share by Application: 2023 VS 2030
Figure 7. Cancer Case Studies
Figure 8. Haemophilia Case Studies
Figure 9. Other Non-Cancer Diseases Case Studies
Figure 10. Bi-Specific Antibodies Report Years Considered
Figure 11. Global Bi-Specific Antibodies Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Bi-Specific Antibodies Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Bi-Specific Antibodies Market Share by Region: 2023 VS 2030
Figure 14. Global Bi-Specific Antibodies Market Share by Players in 2023
Figure 15. Global Top Bi-Specific Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bi-Specific Antibodies as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Bi-Specific Antibodies Revenue in 2023
Figure 17. North America Bi-Specific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Bi-Specific Antibodies Market Share by Country (2019-2030)
Figure 19. United States Bi-Specific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Bi-Specific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Bi-Specific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Bi-Specific Antibodies Market Share by Country (2019-2030)
Figure 23. Germany Bi-Specific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Bi-Specific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Bi-Specific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Bi-Specific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Bi-Specific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Bi-Specific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Bi-Specific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Bi-Specific Antibodies Market Share by Region (2019-2030)
Figure 31. China Bi-Specific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Bi-Specific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Bi-Specific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Bi-Specific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Bi-Specific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Bi-Specific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Bi-Specific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Bi-Specific Antibodies Market Share by Country (2019-2030)
Figure 39. Mexico Bi-Specific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Bi-Specific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Bi-Specific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Bi-Specific Antibodies Market Share by Country (2019-2030)
Figure 43. Turkey Bi-Specific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Bi-Specific Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Roche (Chugai) Revenue Growth Rate in Bi-Specific Antibodies Business (2019-2024)
Figure 46. Amgen Revenue Growth Rate in Bi-Specific Antibodies Business (2019-2024)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
